Association of Genetic Variants in miR-217 Gene with Risk of Coronary Artery Disease : A Case-Control Study
© 2021 Han et al..
OBJECTIVE: To evaluate the associations of genetic variants of the miR-217 gene with coronary artery disease (CAD) risk, as well as plasma level of vascular endothelial growth factor (VEGF).
METHODS: A case-control study with 498 CAD patients and 499 frequency-matched healthy controls was conducted to evaluate the associations of four tagSNPs of the miR-217 gene, including rs6724872, rs4999828, rs10206823, and rs41291177, with CAD risk and plasma level of VEGF.
RESULTS: SNP rs6724872 and rs4999828 were significantly associated with increased risk of CAD (P value was smaller than 0.05 even after Bonferroni multiple adjustment). Compared with the G allele, C allele of rs6724872 was significantly associated with 1.73-fold increased risk of CAD (95% CI: 1.25-2.39; P = 0.001). While C allele of rs4999828 was significantly associated with 1.75-fold increased risk of CAD, compared with T allele (95% CI: 1.34-2.29; P = 4 × 10-5). Meanwhile, rs6724872 and rs4999828 were also significantly associated with higher level of VEGF (P < 0.001).
CONCLUSION: These findings highlighted the important role of genetic variants of the miR-217 gene in the pathogenesis of CAD and potential targets for intervention.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
---|---|
Enthalten in: |
Pharmacogenomics and personalized medicine - 14(2021) vom: 23., Seite 1081-1086 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Han, Xia [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Revised 26.04.2022 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.2147/PGPM.S324767 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM330261002 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM330261002 | ||
003 | DE-627 | ||
005 | 20231225210913.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2147/PGPM.S324767 |2 doi | |
028 | 5 | 2 | |a pubmed24n1100.xml |
035 | |a (DE-627)NLM330261002 | ||
035 | |a (NLM)34483680 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Han, Xia |e verfasserin |4 aut | |
245 | 1 | 0 | |a Association of Genetic Variants in miR-217 Gene with Risk of Coronary Artery Disease |b A Case-Control Study |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 26.04.2022 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a © 2021 Han et al. | ||
520 | |a OBJECTIVE: To evaluate the associations of genetic variants of the miR-217 gene with coronary artery disease (CAD) risk, as well as plasma level of vascular endothelial growth factor (VEGF) | ||
520 | |a METHODS: A case-control study with 498 CAD patients and 499 frequency-matched healthy controls was conducted to evaluate the associations of four tagSNPs of the miR-217 gene, including rs6724872, rs4999828, rs10206823, and rs41291177, with CAD risk and plasma level of VEGF | ||
520 | |a RESULTS: SNP rs6724872 and rs4999828 were significantly associated with increased risk of CAD (P value was smaller than 0.05 even after Bonferroni multiple adjustment). Compared with the G allele, C allele of rs6724872 was significantly associated with 1.73-fold increased risk of CAD (95% CI: 1.25-2.39; P = 0.001). While C allele of rs4999828 was significantly associated with 1.75-fold increased risk of CAD, compared with T allele (95% CI: 1.34-2.29; P = 4 × 10-5). Meanwhile, rs6724872 and rs4999828 were also significantly associated with higher level of VEGF (P < 0.001) | ||
520 | |a CONCLUSION: These findings highlighted the important role of genetic variants of the miR-217 gene in the pathogenesis of CAD and potential targets for intervention | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a VEGF | |
650 | 4 | |a coronary artery disease | |
650 | 4 | |a genetic | |
650 | 4 | |a miR-217 | |
700 | 1 | |a Liang, Xiaotang |e verfasserin |4 aut | |
700 | 1 | |a Wu, Menghai |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Lijun |e verfasserin |4 aut | |
700 | 1 | |a Jiang, Honglei |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Pharmacogenomics and personalized medicine |d 2008 |g 14(2021) vom: 23., Seite 1081-1086 |w (DE-627)NLM199504865 |x 1178-7066 |7 nnns |
773 | 1 | 8 | |g volume:14 |g year:2021 |g day:23 |g pages:1081-1086 |
856 | 4 | 0 | |u http://dx.doi.org/10.2147/PGPM.S324767 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 14 |j 2021 |b 23 |h 1081-1086 |